Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Perinatal Medicine
|
January 1, 1997
Risk indicators for neonatal early-onset GBS-related disease. A case-control study
S Bramer, F H van Wijk, B W Mol, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
August 29, 2002
Administration of low molecular weight heparin within two hours before caesarean section increases the risk of wound haematoma
F H van Wijk, H Wolf, J M J Piek, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
February 8, 2006
Recurrent endometrial cancer: a retrospective study
F H van Wijk, F J Huikeshoven, L Abdulkadir, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 4, 2006
Stage III and IV endometrial cancer: a 20-year review of patients
F H van Wijk, F J Huikeshoven, L Abdulkadir, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 2, 2009
Management of recurrent endometrioid endometrial carcinoma: an overview
F H van Wijk, M E L van der Burg, Curt W Burger, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 2, 2009
Management of surgical stage III and IV endometrioid endometrial carcinoma: an overview
F H van Wijk, M E L van der Burg, Curt W Burger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 31, 2002
Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group
F H van Wijk, C Lhommé, G Bolis, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 2, 2004
Molecular portrait of the progestagenic and estrogenic actions of tibolone: behavior of cellular networks in response to tibolone
P Hanifi-Moghaddam, S C J P Gielen, H J Kloosterboer, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
January 18, 2007
Molecular analysis of human endometrium: short-term tibolone signaling differs significantly from estrogen and estrogen + progestagen signaling
P Hanifi-Moghaddam, B Boers-Sijmons, A H A Klaassens, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 9, 2003
Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group
M S Aapro, F H van Wijk, M E L van der Burg, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Perinatal Medicine
|
January 1, 1997
Risk indicators for neonatal early-onset GBS-related disease. A case-control study
S Bramer, F H van Wijk, B W Mol, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
August 29, 2002
Administration of low molecular weight heparin within two hours before caesarean section increases the risk of wound haematoma
F H van Wijk, H Wolf, J M J Piek, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
February 8, 2006
Recurrent endometrial cancer: a retrospective study
F H van Wijk, F J Huikeshoven, L Abdulkadir, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 4, 2006
Stage III and IV endometrial cancer: a 20-year review of patients
F H van Wijk, F J Huikeshoven, L Abdulkadir, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 2, 2009
Management of recurrent endometrioid endometrial carcinoma: an overview
F H van Wijk, M E L van der Burg, Curt W Burger, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 2, 2009
Management of surgical stage III and IV endometrioid endometrial carcinoma: an overview
F H van Wijk, M E L van der Burg, Curt W Burger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 31, 2002
Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group
F H van Wijk, C Lhommé, G Bolis, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 2, 2004
Molecular portrait of the progestagenic and estrogenic actions of tibolone: behavior of cellular networks in response to tibolone
P Hanifi-Moghaddam, S C J P Gielen, H J Kloosterboer, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
January 18, 2007
Molecular analysis of human endometrium: short-term tibolone signaling differs significantly from estrogen and estrogen + progestagen signaling
P Hanifi-Moghaddam, B Boers-Sijmons, A H A Klaassens, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 9, 2003
Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group
M S Aapro, F H van Wijk, M E L van der Burg, et al.
Page
of 2